La Jolla Pharmaceutical Company (LJPC) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 06/16/2019 1 month $9.71 $9.24 -4.84% 4 Ended
Comments: High Risk. Speculation. Slow market. Stock Overpriced
laurvp laurvp 12/07/2015 1 month $29.17 $22.91 -21.46% 21 Ended
alicetta alicetta 11/04/2014 1 Year $11.07 $28.75 +159.71% 159 Ended
Joward Joward 02/26/2014 1 Year $9.10 $20.19 +121.87% 121 Ended
villanueva villanueva 02/26/2014 1 Year $9.14 $20.19 +120.9% 120 Ended
markrefuerzo markrefuerzo 02/26/2014 1 Year $8.95 $20.19 +125.59% 125 Ended
InvestorsXpress InvestorsXpress 02/26/2014 3 months $7.60 $7.58 -0.26% -1 Ended
Comments: 70% chance phase two efficacy should be met!
fdr2010 fdr2010 03/01/2010 3 months N/A Ended
JCdeR JCdeR 02/28/2010 3 months N/A Ended
Comments: LJPC is going ....
MoMoney_1 MoMoney_1 02/09/2010 3 months N/A Ended
CeeDee CeeDee 02/03/2010 3 months N/A Ended
Comments: ...will however come at least back to 0.2
tigre173 tigre173 12/17/2009 3 months N/A Ended
Chadi A. Chadi A. 12/12/2009 3 months N/A Ended
Comments: The best ..The new drug it will be approved
musicmag musicmag 12/09/2009 3 months N/A Ended
bruno_1 bruno_1 12/08/2009 3 months N/A Ended
Comments: popup for tomorrow
moe1 moe1 12/07/2009 3 months N/A Ended

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.